Freedom Investing Report
  • Sports
  • Politics
  • Stocks
  • Business
  • Sports
  • Politics
  • Stocks
  • Business

Freedom Investing Report

Sports

Player makes NBA debut months after cancer diagnosis

by February 13, 2026
February 13, 2026
Player makes NBA debut months after cancer diagnosis

Oklahoma City Thunder guard Nikola Topić made his NBA debut against the Milwaukee Bucks on Thursday night, four months after he was diagnosed with cancer.

The 6-foot-6 Serbian had been unavailable after being diagnosed with testicular cancer in October and undergoing chemotherapy.

He received a standing ovation from the home crowd at Paycom Center after checking into the game with 1:55 left in the first quarter.

Topić was the 12th overall pick in the first round of the 2024 NBA Draft by the Thunder. He played in just one preseason game before having surgery and undergoing chemotherapy.

Topić went 1-for-3 from the field, scoring his first official NBA points, in 12 minutes. He also had a rebound and an assist.

This post appeared first on USA TODAY
previous post
2026 Daytona Duels results: Logano, Elliott edge out competitors
next post
LeBron James becomes oldest NBA player to record triple-double

Related Posts

Spurs release former All-Rookie player: What we know

February 12, 2026

USA’s Jessie Diggins fights through injury to claim...

February 12, 2026

Ilia Malinin gets standing ovation after short program:...

February 11, 2026

Are the Dodgers ruining baseball? Their rivals disagree.

February 13, 2026

USA men’s hockey vs Latvia live score, updates,...

February 12, 2026

Live: Super Bowl 60 champion Seattle Seahawks victory...

February 9, 2026

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (3)
    • Sports (315)
    • About Us
    • Contacts
    • Terms & Conditions
    • Privacy Policy
    • Email Whitelisting

    Disclaimer: FreedomInvestingReport.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2023 FreedomInvestingReport.com | All Rights Reserved